{"organizations": [], "uuid": "8f2a10a46e9b7e81ca9a42e115beb1c89e216dad", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180208.html", "section_title": "Archive News &amp; Video for Thursday, 08 Feb 2018 | Reuters.com", "url": "https://www.reuters.com/article/idUSH9N1PV01S", "country": "US", "domain_rank": 408, "title": "CORRECTED-BRIEF-Livzon Pharmaceutical Unit's JV Livzon Biologics' Capital Will Be Boosted By 600 Mln Yuan (Feb 7)", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 1.0, "site_type": "news", "published": "2018-02-07T20:06:00.000+02:00", "replies_count": 0, "uuid": "8f2a10a46e9b7e81ca9a42e115beb1c89e216dad"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/idUSH9N1PV01S", "ord_in_thread": 0, "title": "CORRECTED-BRIEF-Livzon Pharmaceutical Unit's JV Livzon Biologics' Capital Will Be Boosted By 600 Mln Yuan (Feb 7)", "locations": [], "entities": {"persons": [{"name": "liv", "sentiment": "negative"}], "locations": [{"name": "u.s.", "sentiment": "none"}, {"name": "hong kong", "sentiment": "none"}], "organizations": [{"name": "reuters", "sentiment": "negative"}, {"name": "corrected-brief-livzon pharmaceutical unit", "sentiment": "negative"}, {"name": "zon pharmaceutical group inc", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "(Corrects currency unit in headline and bullet point to yuan, not U.S. dollar)\nFeb 7 (Reuters) - Livzon Pharmaceutical Group Inc :\n* SAYS CAPITAL AT UNIT'S JV LIVZON BIOLOGICS WILL BE BOOSTED BY 600 MILLION YUAN ($94.94 million) Source text in Chinese: bit.ly/2nMWH27 Further company coverage: ($1 = 6.3201 Chinese yuan renminbi) (Reporting by Hong Kong newsroom)\n ", "external_links": ["http://thomsonreuters.com/en/about-us/trust-principles.html", "http://bit.ly/2nMWH27"], "published": "2018-02-07T20:06:00.000+02:00", "crawled": "2018-02-09T16:32:13.017+02:00", "highlightTitle": ""}